Clinical Laser Therapies for Ophthalmology, Dermatology, and Vascular Interventions
This research community focuses on the clinical application of laser technology to treat conditions in the eye, skin, and blood vessels, with a primary emphasis on evaluating the safety and efficacy of these interventions through rigorous clinical trials.
The work centers on specific laser modalities, including YAG, excimer, CO2, and femtosecond lasers, applied to procedures such as photorefractive keratectomy, lenticule extraction, and intravascular lithotripsy. A significant portion of the literature involves photobiomodulation therapy and the management of corneal and glaucoma-related conditions. The methodology is heavily weighted toward randomized controlled trials, systematic meta-analyses, and case reports, reflecting a strong focus on evidence-based clinical outcomes and comparative safety profiles across these diverse medical applications.
The community is most prominent in research involving Yttrium, where it accounts for 4.7% of all Yttrium-related papers, and Neodymium, representing 5.9% of that element's research. It also contributes 3.2% of Erbium research. These elements are integral to the laser systems described, such as YAG and Nd:YAG lasers, which are central to the therapeutic procedures documented in this field.
The community comprises 43,754 papers, with the highest publication volumes in Ophthalmic Surgery, Lasers and Imaging Retina, Dermatologic Therapy, and Lasers in Medical Science. Recent work continues to explore the molecular mechanisms of photobiomodulation, including its effects on inflammation and tissue healing, alongside updated clinical guidelines for managing acute glaucoma and evaluating the long-term safety of laser-assisted delivery systems.